Showing results (1751-1760 of 1,946) with videos related to

Sort By:
Pageof 195
International Journal of Radiation Oncology, Biology, Physics|January 7, 2019
Five-Year Outcomes of a Phase 1 Dose-Escalation Study Using Stereotactic Body Radiosurgery for Patients With Low-Risk and Intermediate-Risk Prostate CancerMichael J Zelefsky, Marisa Kollmeier, Sean McBride, et al.
Journal of Clinical and Experimental Hepatology|July 27, 2021
Evaluation of Liver Histopathological Findings of Coronavirus Disease 2019 by Minimally Invasive AutopsiesVikarn Vishwajeet, Abhishek Purohit, Deepak Kumar, et al.
Cerebrovascular Diseases Extra|November 16, 2016
Risk Factors for Incident Carotid Artery Revascularization among Older Adults: The Cardiovascular Health StudyParveen K Garg, Willam J H Koh, Joseph A Delaney, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 31, 2023
Association of diabetes and glycemic control with left atrial function: The Atherosclerosis Risk in Communities (ARIC) studyParveen K Garg, Yuekai Ji, Wendy Wang, et al.
The Journal of Biological Chemistry|February 24, 2024
Triple-fusion protein (TriFu): A potent, targeted, enzyme-like inhibitor of all three complement activation pathwaysSophia J Sonnentag, Arthur Dopler, Katharina Kleiner, et al.
Diabetes Care|April 2, 2026
Differences in Clinical Manifestations and Islet Autoantibodies by Age in Adult-Onset Type 1 DiabetesKagan E Karakus, Maia G Clayton, Erin E Baschal, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early OutcomesPaul B Romesser, Oren Cahlon, Eli D Scher, et al.
Diabetes Care|June 8, 2015
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 DiabetesArthur T Sands, Brian P Zambrowicz, Julio Rosenstock, et al.
Pageof 195